TY - JOUR
T1 - Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes
T2 - A nested case-control study within a cohort of U.S. radiologic technologists
AU - Lönn, Stefan
AU - Bhatti, Parveen
AU - Alexander, Bruce H.
AU - Pineda, Marbin A.
AU - Doody, Michele M.
AU - Struewing, Jeffery P.
AU - Sigurdson, Alice J.
PY - 2007/1
Y1 - 2007/1
N2 - Several variants in the TSHR and RET signaling pathways genes have been reported to be related to cancer risk. We hypothesized that polymorphic variants in these genes are associated with the risk of papillary thyroid cancer. A nested case-control study was conducted within the U.S. Radiologic Technologists cohort. Eligible validated papillary thyroid cancer cases (n = 167) and frequency-matched (by sex and birth year) controls (n = 491) donated blood for analysis. There were no statistically significant associations between papillary thyroid cancer and 10 selected polymorphic variants in analyses of men and women combined. A borderline significant increasing risk was found for RET G691S (Ptrend = 0.05) and was especially pronounced among young women. For women under 38 years (the median age at diagnosis), the odds ratios were 2.1 (95% confidence interval, 1.2-3.7) for those heterozygous for the RET G691S polymorphism and 3.7 (95% confidence interval, 1.1-11.8) for those who were homozygous (Ptrend = 0.001). Our data provide limited evidence that TSHR- and RET-related genes are related to papillary thyroid cancer risk.
AB - Several variants in the TSHR and RET signaling pathways genes have been reported to be related to cancer risk. We hypothesized that polymorphic variants in these genes are associated with the risk of papillary thyroid cancer. A nested case-control study was conducted within the U.S. Radiologic Technologists cohort. Eligible validated papillary thyroid cancer cases (n = 167) and frequency-matched (by sex and birth year) controls (n = 491) donated blood for analysis. There were no statistically significant associations between papillary thyroid cancer and 10 selected polymorphic variants in analyses of men and women combined. A borderline significant increasing risk was found for RET G691S (Ptrend = 0.05) and was especially pronounced among young women. For women under 38 years (the median age at diagnosis), the odds ratios were 2.1 (95% confidence interval, 1.2-3.7) for those heterozygous for the RET G691S polymorphism and 3.7 (95% confidence interval, 1.1-11.8) for those who were homozygous (Ptrend = 0.001). Our data provide limited evidence that TSHR- and RET-related genes are related to papillary thyroid cancer risk.
UR - http://www.scopus.com/inward/record.url?scp=33846572959&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846572959&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-06-0665
DO - 10.1158/1055-9965.EPI-06-0665
M3 - Article
C2 - 17220349
AN - SCOPUS:33846572959
VL - 16
SP - 174
EP - 177
JO - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
JF - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
SN - 1055-9965
IS - 1
ER -